Literature DB >> 24633719

What interventions improve walking ability in neurogenic claudication with lumbar spinal stenosis? A systematic review.

Carlo Ammendolia1, Kent Stuber, Christy Tomkins-Lane, Michael Schneider, Y Raja Rampersaud, Andrea D Furlan, Carol A Kennedy.   

Abstract

PURPOSE: To investigate what interventions can improve walking ability in neurogenic claudication with lumbar spinal stenosis.
METHODS: We searched CENTRAL, Medline, EMBASE, CINAHL and ICL databases up to June 2012. Only randomized controlled trials published in English and measuring walking ability were included. Data extraction, risk of bias assessment, and quality of the evidence evaluation were performed using methods of the Cochrane Back Review Group.
RESULTS: We accepted 18 studies with 1,220 participants. There is very low quality evidence that calcitonin is no better than placebo or paracetamol regardless of mode of administration. There is low quality evidence that prostaglandins, and very low quality evidence that gabapentin or methylcobalamin, improves walking distance. There is low and very low quality evidence that physical therapy was no better in improving walking ability compared to no treatment, oral diclofenac plus home exercises, or combined manual therapy and exercise. There is very low quality evidence that epidural injections improve walking distance up to 2 weeks compared to placebo. There is low- and very low-quality evidence that various direct decompression surgical techniques show similar significant improvements in walking ability. There is low quality evidence that direct decompression is no better than non-operative treatment in improving walking ability. There is very low quality evidence that indirect decompression improves walking ability compared to non-operative treatment.
CONCLUSIONS: Current evidence for surgical and non-surgical treatment to improve walking ability is of low and very low quality and thus prohibits recommendations to guide clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633719     DOI: 10.1007/s00586-014-3262-6

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  60 in total

1.  Effectiveness of salmon calcitonin nasal spray in the treatment of lumbar canal stenosis: a double-blind, randomized, placebo-controlled, parallel group trial.

Authors:  Vinod K Podichetty; Allen M Segal; Michael Lieber; Daniel J Mazanec
Journal:  Spine (Phila Pa 1976)       Date:  2004-11-01       Impact factor: 3.468

2.  2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group.

Authors:  Andrea D Furlan; Victoria Pennick; Claire Bombardier; Maurits van Tulder
Journal:  Spine (Phila Pa 1976)       Date:  2009-08-15       Impact factor: 3.468

3.  A multicenter, prospective, randomized trial evaluating the X STOP interspinous process decompression system for the treatment of neurogenic intermittent claudication: two-year follow-up results.

Authors:  James F Zucherman; Ken Y Hsu; Charles A Hartjen; Thomas F Mehalic; Dante A Implicito; Michael J Martin; Donald R Johnson; Grant A Skidmore; Paul P Vessa; James W Dwyer; Stephen T Puccio; Joseph C Cauthen; Richard M Ozuna
Journal:  Spine (Phila Pa 1976)       Date:  2005-06-15       Impact factor: 3.468

Review 4.  Lumbar spinal stenosis: a brief review of the nonsurgical management.

Authors:  De Q H Tran; Silvia Duong; Roderick J Finlayson
Journal:  Can J Anaesth       Date:  2010-04-29       Impact factor: 5.063

Review 5.  Does this older adult with lower extremity pain have the clinical syndrome of lumbar spinal stenosis?

Authors:  Pradeep Suri; James Rainville; Leonid Kalichman; Jeffrey N Katz
Journal:  JAMA       Date:  2010-12-15       Impact factor: 56.272

6.  Correlation of patient satisfaction with symptom severity and walking ability after surgical treatment for degenerative lumbar spinal stenosis.

Authors:  Kazuo Yamashita; Junzo Hayashi; Kenji Ohzono; Kazuo Hiroshima
Journal:  Spine (Phila Pa 1976)       Date:  2003-11-01       Impact factor: 3.468

7.  The effect of body position and axial load on spinal canal morphology: an MRI study of central spinal stenosis.

Authors:  Rasmus Madsen; Tue Secher Jensen; Malcolm Pope; Joan Solgaard Sørensen; Tom Bendix
Journal:  Spine (Phila Pa 1976)       Date:  2008-01-01       Impact factor: 3.468

8.  The efficiency of gabapentin therapy in patients with lumbar spinal stenosis.

Authors:  Ali Yaksi; Levent Ozgönenel; Bülent Ozgönenel
Journal:  Spine (Phila Pa 1976)       Date:  2007-04-20       Impact factor: 3.468

9.  Health-related quality of life (EQ-5D) before and one year after surgery for lumbar spinal stenosis.

Authors:  K-A Jansson; G Németh; F Granath; B Jönsson; P Blomqvist
Journal:  J Bone Joint Surg Br       Date:  2009-02

10.  The efficacy of physical therapy and physical therapy plus calcitonin in the treatment of lumbar spinal stenosis.

Authors:  Fusun Sahin; Figen Yilmaz; Nurdan Kotevoglu; Banu Kuran
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more
  22 in total

Review 1.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2014.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2014-12-06       Impact factor: 3.134

Review 2.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "surgical research" articles in the European Spine Journal 2014.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2015-01-03       Impact factor: 3.134

3.  Degenerative lumbar spinal stenosis and its imposters: three case studies.

Authors:  Carlo Ammendolia
Journal:  J Can Chiropr Assoc       Date:  2014-09

4.  Correlation between the Oswestry Disability Index and objective measurements of walking capacity and performance in patients with lumbar spinal stenosis: a systematic literature review.

Authors:  Annette Bennedsgaard Jespersen; Malin Eleonora Av Kák Gustafsson
Journal:  Eur Spine J       Date:  2018-03-05       Impact factor: 3.134

5.  Validation of a novel range of motion assessment tool for the cervical spine: the HALO© digital goniometer.

Authors:  Ashley R Wilson-Smith; Saimurooban Muralidaran; Monish Maharaj; Matthew H Pelletier; Peter Beshara; Prashanth Rao; Louise M Pearce; Tian Wang; Ralph J Mobbs; William R Walsh
Journal:  J Spine Surg       Date:  2022-03

6.  Objective measurement of function following lumbar spinal stenosis decompression reveals improved functional capacity with stagnant real-life physical activity.

Authors:  Matthew Smuck; Amir Muaremi; Patricia Zheng; Justin Norden; Aman Sinha; Richard Hu; Christy Tomkins-Lane
Journal:  Spine J       Date:  2017-09-28       Impact factor: 4.166

7.  The physical and psychological impact of neurogenic claudication: the patients' perspectives.

Authors:  Carlo Ammendolia; Michael Schneider; Kelly Williams; Susan Zickmund; Megan Hamm; Kent Stuber; Christy Tomkins-Lane; Y Raja Rampersaud
Journal:  J Can Chiropr Assoc       Date:  2017-03

8.  The efficacy of intramuscular calcitonin injection in the management of lumbar spinal stenosis.

Authors:  Alireza Ashraf; Mehdi Khodadadi; Amin Sadraei; Mahshid Naseri; Ali Nasseri
Journal:  Asian Spine J       Date:  2015-02-13

9.  ISSLS Prize Winner: Consensus on the Clinical Diagnosis of Lumbar Spinal Stenosis: Results of an International Delphi Study.

Authors:  Christy Tomkins-Lane; Markus Melloh; Jon Lurie; Matt Smuck; Michele C Battié; Brian Freeman; Dino Samartzis; Richard Hu; Thomas Barz; Kent Stuber; Michael Schneider; Andrew Haig; Constantin Schizas; Jason Pui Yin Cheung; Anne F Mannion; Lukas Staub; Christine Comer; Luciana Macedo; Sang-Ho Ahn; Kazuhisa Takahashi; Danielle Sandella
Journal:  Spine (Phila Pa 1976)       Date:  2016-08-01       Impact factor: 3.241

10.  Prediction of walking ability following posterior decompression for lumbar spinal stenosis.

Authors:  Suzanne McIlroy; Feroz Jadhakhan; David Bell; Alison Rushton
Journal:  Eur Spine J       Date:  2021-08-05       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.